(Q37962078)

26 August 2017

title

Epidemiology of major eye diseases leading to blindness in Europe: a literature review (English)

1 reference

26 August 2017

1 reference

Elena Prokofyeva

1

1 reference

26 August 2017

Eberhart Zrenner

series ordinal

2

1 reference

26 August 2017

publication date

26 November 2011

1 reference

26 August 2017

1 reference

26 August 2017

volume

47

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

171-188

1 reference

Visual impairment and blindness in Europe and their prevention

26 August 2017

cites work

1 reference

The prevalence of age-related maculopathy by geographic region and ethnicity

21 January 2018

1 reference

Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study

21 January 2018

1 reference

Prevalence of lens opacities in Latinos: the Los Angeles Latino Eye Study

21 January 2018

1 reference

Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study.

21 January 2018

1 reference

Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study

21 January 2018

1 reference

The prevalence of open-angle glaucoma among blacks and whites 73 years and older: the Salisbury Eye Evaluation Glaucoma Study

21 January 2018

1 reference

Risk factors for age-related macular degeneration: Pooled findings from three continents.

21 January 2018

1 reference

Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE).

21 January 2018

1 reference

The incidence of visual impairment and its determinants in the WHO Multinational Study of Vascular Disease in Diabetes

21 January 2018

1 reference

Epidemiology of diabetes-induced blindness -- a review

21 January 2018

1 reference

The age distribution of primary open angle glaucoma

21 January 2018

1 reference

Epidemiology of age-related cataract

21 January 2018

1 reference

The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study

21 January 2018

1 reference

Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration

21 January 2018

1 reference

How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?

21 January 2018

1 reference

Ethnic differences in diabetic retinopathy

21 January 2018

1 reference

The appearance of retinopathy and progression to proliferative retinopathy: the WHO Multinational Study of Vascular Disease in Diabetes

21 January 2018

1 reference

[Population-based study of diabetic retinopathy in Wolfsburg]

21 January 2018

1 reference

Prevalence and risk factors of diabetic retinopathy in adult and elderly subjects: The Casteldaccia Eye Study

21 January 2018

1 reference

Prevalence of diabetic retinopathy and eye care in a rural area of Spain

21 January 2018

1 reference

Causes of incident visual field loss in a general elderly population: the Rotterdam study

21 January 2018

1 reference

The French glaucoma and ocular hypertension 1-day study

21 January 2018

1 reference

Prevalence of glaucoma in Ponza, Italy: a comparison with other studies.

21 January 2018

1 reference

The projected increase in glaucoma due to an ageing population

21 January 2018

1 reference

Prevalence of primary open angle glaucoma in general ophthalmic practice in the United Kingdom

21 January 2018

1 reference

Epidemiology of blindness and eye disease

21 January 2018

1 reference

Effects of verteporfin therapy on contrast on sensitivity: Results From the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation-TAP report No 4.

21 January 2018

1 reference

Progression of visual loss and time between initial assessment and treatment of wet age-related macular degeneration

21 January 2018

1 reference

Retinal precursors and the development of geographic atrophy in age-related macular degeneration.

21 January 2018

1 reference

Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study

21 January 2018

1 reference

A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration.

21 January 2018

1 reference

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

21 January 2018

1 reference

Cost utility of photodynamic therapy for predominantly classic neovascular age related macular degeneration

21 January 2018

1 reference

Incremental cost effectiveness of laser photocoagulation for subfoveal choroidal neovascularization

21 January 2018

1 reference

A value-based medicine comparison of interventions for subfoveal neovascular macular degeneration

21 January 2018

1 reference

CME review: A cost-utility analysis of laser photocoagulation for extrafoveal choroidal neovascularization

21 January 2018

1 reference

Cost effectiveness of treatments for wet age-related macular degeneration

21 January 2018

1 reference

Common eye diseases of elderly people: identifying and treating causes of vision loss

21 January 2018

1 reference

Simulation of diabetic eye disease to compare screening policies

21 January 2018

1 reference

QALY: an ethical issue that dare not speak its name

21 January 2018

1 reference

Screening models for glaucoma

21 January 2018

1 reference

Worldwide glaucoma through the looking glass

21 January 2018

1 reference

The Bristol shared care glaucoma study: outcome at follow up at 2 years

21 January 2018

1 reference

The epidemiology of medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994 to 2003.

21 January 2018

1 reference

Incidence of blindness in southern Germany due to glaucoma and degenerative conditions

21 January 2018

1 reference

The number of people with glaucoma worldwide in 2010 and 2020

21 January 2018

1 reference

The Finnish evidence-based guideline for open-angle glaucoma.

21 January 2018

1 reference

Awareness of glaucoma, and health beliefs of patients suffering primary acute angle closure

21 January 2018

1 reference

Ocular Hypertension Treatment Study (OHTS) commentary

21 January 2018

1 reference

Medical costs of glaucoma and ocular hypertension in Italian referral centres: a prospective study.

21 January 2018

1 reference

Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe

21 January 2018

1 reference

The effects of nasolacrimal canal blockage on topical medications for glaucoma.

21 January 2018

1 reference

The economic implications of glaucoma: a literature review

21 January 2018

1 reference

Prostaglandin analogues for the treatment of glaucoma and ocular hypertension: a systematic review of economic evidence

21 January 2018

1 reference

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group

21 January 2018

1 reference

Classification and treatment of diabetic retinopathy

21 January 2018

1 reference

Prevalence and predictors of open-angle glaucoma: results from the visual impairment project

21 January 2018

1 reference

2002 global update of available data on visual impairment: a compilation of population-based prevalence studies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000329603

1 reference

26 August 2017

1 reference